Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul-Dec;11(22):104-122.
doi: 10.4103/phrev.phrev_8_17.

Plants' Natural Products as Alternative Promising Anti- Candida Drugs

Affiliations
Review

Plants' Natural Products as Alternative Promising Anti- Candida Drugs

Sameh Soliman et al. Pharmacogn Rev. 2017 Jul-Dec.

Abstract

Candida is a serious life-threatening pathogen, particularly with immunocompromised patients. Candida infections are considered as a major cause of morbidity and mortality in a broad range of immunocompromised patients. Candida infections are common in hospitalized patients and elderly people. The difficulty to eradicate Candida infections is owing to its unique switch between yeast and hyphae forms and more likely to biofilm formations that render resistance to antifungal therapy. Plants are known sources of natural medicines. Several plants show significant anti-Candida activities and some of them have lower minimum inhibitory concentration, making them promising candidates for anti-Candida therapy. However, none of these plant products is marketed for anti-Candida therapy because of lack of sufficient information about their efficacy, toxicity, and kinetics. This review revises major plants that have been tested for anti-Candida activities with recommendations for further use of some of these plants for more investigation and in vivo testing including the use of nanostructure lipid system.

Keywords: Anti-Candida; Candida; biofilm; natural products; plants.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Representative drawing of the active sites and mechanisms of most tested plant anti-Candida agents
Figure 2
Figure 2
Simplified flow chart showing the utilization of different biotechnological approaches for identifying, developing, and enhancing the production levels of anti-Candida candidate compounds from a plant source

References

    1. d’Enfert C. Hidden killers: Persistence of opportunistic fungal pathogens in the human host. Curr Opin Microbiol. 2009;12:358–64. - PubMed
    1. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area 1992-1993: Results of population-based laboratory active surveillance. Clin Infect Dis. 1998;27:1138–47. - PubMed
    1. Schulze J, Sonnenborn U. Yeasts in the gut: From commensals to infectious agents. Dtsch Arztebl Int. 2009;106:837–42. - PMC - PubMed
    1. Hamad M, Kazandji N, Awadallah S, Allam H. Prevalence and epidemiological characteristics of vaginal candidiasis in the UAE. Mycoses. 2014;57:184–90. - PubMed
    1. Sydnor ER, Perl TM. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev. 2011;24:141–73. - PMC - PubMed

LinkOut - more resources